These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6457532)
1. Long-term isografts of cultured fetal mouse pancreatic islets. The oncogenic effects of streptozotocin and the prevention of diabetic renal complications. Mandel TE; Hoffman L; Carter WM Am J Pathol; 1981 Sep; 104(3):227-36. PubMed ID: 6457532 [TBL] [Abstract][Full Text] [Related]
3. Islet cell subpopulations in cultured mouse fetal pancreas and pancreatic isografts. Georgiou HM; Mandel TE Transplant Proc; 1984 Aug; 16(4):1055-6. PubMed ID: 6431665 [TBL] [Abstract][Full Text] [Related]
4. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats. Adewole SO; Ojewole JA Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509 [TBL] [Abstract][Full Text] [Related]
5. Effects of cadmium exposure on morphological aspects of pancreas, weights of fetus and placenta in streptozotocin-induced diabetic pregnant rats. Kanter M; Yoruk M; Koc A; Meral I; Karaca T Biol Trace Elem Res; 2003; 93(1-3):189-200. PubMed ID: 12835501 [TBL] [Abstract][Full Text] [Related]
6. Neonatal islet cell transplantation in the diabetic rat: effect on the renal complications. Slater DN; Mangnall Y; Smythe A; Ward AM; Fox M J Pathol; 1978 Feb; 124(2):117-24. PubMed ID: 152805 [TBL] [Abstract][Full Text] [Related]
7. Recovery in the fetal pancreatic islet following fetal administration of streptozotocin in the rat in vivo and in vitro. Yamamoto M; Yasuda M; Hori A; Arishima K; Eguchi Y Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1319-25. PubMed ID: 15515161 [TBL] [Abstract][Full Text] [Related]
8. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model. Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226 [TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
10. Survival of islet isografts despite cytotoxicity against pancreatic islets measured in vitro. Ziegler B; Köhler E; Klöting I; Besch W; Ziegler M Exp Clin Endocrinol; 1990 Feb; 95(1):31-8. PubMed ID: 2139850 [TBL] [Abstract][Full Text] [Related]
11. Tilapia islet grafts are highly alloxan-resistant. Xu BY; Morrison CM; Yang H; Wright JR Gen Comp Endocrinol; 2004 Jun; 137(2):132-40. PubMed ID: 15158125 [TBL] [Abstract][Full Text] [Related]
12. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model. Palm F; Ortsäter H; Hansell P; Liss P; Carlsson PO Diabetes Metab Res Rev; 2004; 20(6):452-9. PubMed ID: 15386825 [TBL] [Abstract][Full Text] [Related]
13. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy. Reddy S; Young M; Poole CA; Ross JM Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice. Kim SJ; Nian C; Doudet DJ; McIntosh CH Diabetes; 2008 May; 57(5):1331-9. PubMed ID: 18299314 [TBL] [Abstract][Full Text] [Related]
15. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection. Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223 [TBL] [Abstract][Full Text] [Related]
16. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice. Ezquer F; Ezquer M; Simon V; Pardo F; Yañez A; Carpio D; Conget P Biol Blood Marrow Transplant; 2009 Nov; 15(11):1354-65. PubMed ID: 19822294 [TBL] [Abstract][Full Text] [Related]
17. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro. Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569 [TBL] [Abstract][Full Text] [Related]
18. Prevention of early loss of transplanted islets in the liver of mice by adenosine. Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680 [TBL] [Abstract][Full Text] [Related]
19. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse. Inada A; Kanamori H; Arai H; Akashi T; Araki M; Weir GC; Fukatsu A J Cell Physiol; 2008 May; 215(2):383-91. PubMed ID: 18270980 [TBL] [Abstract][Full Text] [Related]
20. Long-term effects of insulin therapy, islet transplantation, and pancreas transplantation in the prevention of glomerular changes in kidneys of alloxan-induced diabetic rats. Spadella CT; Lerco MM; Machado JL; Macedo CS Transplant Proc; 2005 Oct; 37(8):3468-71. PubMed ID: 16298631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]